Pulse Biosciences (NASDAQ:PLSE) Shares Gap Down – Time to Sell?

Shares of Pulse Biosciences, Inc. (NASDAQ:PLSEGet Free Report) gapped down before the market opened on Wednesday . The stock had previously closed at $17.54, but opened at $16.37. Pulse Biosciences shares last traded at $16.55, with a volume of 4,945 shares traded.

Analysts Set New Price Targets

Separately, StockNews.com raised Pulse Biosciences to a “sell” rating in a report on Friday, September 20th.

View Our Latest Report on Pulse Biosciences

Pulse Biosciences Trading Down 2.6 %

The stock has a market capitalization of $986.77 million, a price-to-earnings ratio of -19.88 and a beta of 1.75. The company has a fifty day moving average of $17.51 and a two-hundred day moving average of $13.03.

Hedge Funds Weigh In On Pulse Biosciences

Hedge funds and other institutional investors have recently modified their holdings of the stock. BNP Paribas Financial Markets boosted its position in Pulse Biosciences by 63.6% in the 1st quarter. BNP Paribas Financial Markets now owns 7,597 shares of the company’s stock valued at $66,000 after buying an additional 2,952 shares during the last quarter. Quest Partners LLC bought a new stake in Pulse Biosciences in the 2nd quarter valued at $91,000. Price T Rowe Associates Inc. MD bought a new stake in shares of Pulse Biosciences in the first quarter worth $88,000. Cetera Advisors LLC bought a new stake in Pulse Biosciences during the 1st quarter worth about $109,000. Finally, PNC Financial Services Group Inc. bought a new position in shares of Pulse Biosciences in the 4th quarter valued at about $242,000. Institutional investors own 76.95% of the company’s stock.

About Pulse Biosciences

(Get Free Report)

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.

Featured Articles

Receive News & Ratings for Pulse Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.